ArticleNPJ digital medicine2026
Attention guided fair artificial intelligence modeling for skin cancer diagnosis.
Article in NPJ digital medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Artificial intelligence (AI) has shown promise in dermatology, offering accurate and non-invasive diagnosis of skin cancer. While extensive research has addressed skin-tone bias, gender bias in dermatologic AI remains underexplored, potentially perpetuating diagnostic disparities. In this study, we developed LesionAttn, an algorithm designed to mitigate gender bias by directing model attention toward lesions, thereby mirroring clinicians' diagnostic focus. Combined with Pareto Frontier optimization for dual-objective model selection, LesionAttn balances gender fairness and diagnostic performance. Validated on two large-scale dermatologic datasets for binary malignancy classification, LesionAttn significantly mitigated gender bias while maintaining high diagnostic performance, outperforming existing bias-mitigation algorithms. Our study demonstrates that explicitly guiding model attention to medically essential features provides a practical approach to advance both performance and fairness in dermatologic AI. By leveraging clinical priors to bridge the gap between human expertise and algorithmic optimization, this study demonstrates a feasible pathway for developing equitable and reliable diagnostic tools.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.